Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
Open Access
- 29 June 2022
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (3) , e0153822
Abstract
This manuscript describes an extended work on the Newcastle disease virus (NDV)-based vaccine focusing on multivalent formulations of NDV vectors expressing different prefusion-stabilized versions of the spike proteins of different SARS-CoV-2 variants of concern (VOC). We demonstrate here that this low-cost NDV platform can be easily adapted to construct vaccines against SARS-CoV-2 variants.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201400008C)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (75N93021C00014)
- HHS | National Institutes of Health (DK130425/DK/NIDDK)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID R21AI157606)
- Anonymous philanthropist to Mount Sinai (-)
This publication has 31 references indexed in Scilit:
- A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 VaccineVaccines, 2020
- Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidateEBioMedicine, 2020
- SARS-CoV-2 vaccines in developmentNature, 2020
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikesScience, 2020
- SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test SetupCurrent Protocols in Microbiology, 2020
- Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infectionEmerging Microbes & Infections, 2020
- Nextstrain: real-time tracking of pathogen evolutionBioinformatics, 2018
- TreeTime: Maximum-likelihood phylodynamic analysisVirus Evolution, 2018
- Rescue of Recombinant Newcastle Disease Virus from cDNAJournal of Visualized Experiments, 2013
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLOS Medicine, 2006